- 询价
- 辰辉创聚生物
- 中国
- NBAB-139143
- 2025年07月12日
- ELISA, Flow Cytometry, WB
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Cynomolgus Monkey TNF alpha protein
- 形态：
liquid
- 保存条件：
Short term 4℃; Long term -20℃.
- 克隆性：
多克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
辰辉创聚生物
- 应用范围：
ELISA, Flow Cytometry, WB
- 靶点：
Cynomolgus Monkey TNF alpha
- 抗体英文名：
Anti-Cynomolgus Monkey TNF alpha Polyclonal Antibody
- 抗体名：
Cynomolgus Monkey TNF alpha antibody
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名:NebuSelect™ Anti-Cynomolgus Monkey TNF alpha Polyclonal Antibody
货号:NBAB-139143
品牌:Nebulabio
规格:100ul; 500ul; 1ml
| 产品描述
| 产品属性
Product Category：Rabbit PAb
Reactivity：Cynomolgus Monkey
Specificity：Cynomolgus Monkey TNF alpha
Immunogen：Recombinant Cynomolgus Monkey TNF alpha protein
Isotype：Polyclonal Rabbit IgG
Purification：Protein A & Antigen Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：ELISA, Flow Cytometry, WB
Dilution：ELISA 1:2000～1:10000, FC 1:20～1:200, WB 1:500～1:2000
Storage：Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Colloidal Gold: A Novel Nanoparticle for Targeted Cancer Therapeutics
tumors to improve either their safety or efficacy or both. Described in this chapter is the development of one such nanotherapeutic, termed CYT-6091, that targets the delivery of tumor necrosis factor alpha (TNF) to solid tumors. Outlined
Radioactive DNA Fragmentation Assay
DESCRIPTION of the method: The DNA Fragmentation Assay allows to determine the amount of DNA that is degraded upon treatment of cells with certain agents, e.g. with TNF-alpha or anti-Fas antibody (IPO-4).
Methods to Analyze Cellular Necroptosis
Necroptosis is a mechanism of necrotic cell death induced by external stimuli in the form of death domain receptor (DR) engagement by their respective ligands, TNF-alpha, Fas ligand (FasL) and TRAIL, under conditions when apoptotic cell death
技术资料暂无技术资料 索取技术资料
